Summary of article from Dickinson Wright, by Patrick Masterson, Pahl Zinn:
In early 2024, the Biden administration intensified antitrust enforcement, particularly targeting the healthcare sector. December 2023 saw the release of new Merger Guidelines by the FTC and DOJ, lowering thresholds for anti-competitive assessments and focusing on healthcare mergers. February 2024 marked a joint inquiry into private equity’s influence in healthcare, with public comments open until July. The FTC also finalized a rule banning noncompete agreements, extending its jurisdiction to certain nonprofit healthcare entities. Additionally, the DOJ established a Task Force on Health Care Monopolies and Collusion to address antitrust issues in the sector.